Form 4 for HCA HCA Healthcare
Accepted 2026-02-02 00:00:00 ET · period of report 2026-01-29 · accession 0001193125-26-034005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-02 | 2026-01-30 | HCA | HAZEN SAMUEL N | CEO, Dir | M - OptEx | $81.96 | +84.4K | 116.6K | +261% | +$6.91M |
| D | 2026-02-02 | 2026-01-30 | HCA | HAZEN SAMUEL N | CEO, Dir | F - Tax | $488.27 | -41.5K | 75.2K | -36% | -$20.25M |
| D | 2026-02-02 | 2026-01-30 | HCA | HAZEN SAMUEL N | CEO, Dir | M - OptEx | $0.00 | -84.4K | 0 | -100% | $0 |
| D | 2026-02-02 | 2026-01-29 | HCA | HAZEN SAMUEL N | CEO, Dir | A - Grant | $0.00 | +55.8K | 55.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-01-30 | M | A | 84,360 | $81.96 | 116,636 | D | — | — | |
| 2 | Common | Common Stock | 2026-01-30 | F | D | 41,483 | $488.27 | 75,153 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2026-01-30 | M | D | 84,360 | $0.00 | 0 | D | $81.96 · — to 2027-02-01 | 84,360 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on February 1, 2018. |
| 4 | Derivative | Stock Appreciation Right | 2026-01-29 | A | A | 55,846 | $0.00 | 55,846 | D | $482.53 · 2027-01-29 to 2036-01-29 | 55,846 Common Stock | (F1) The stock appreciation rights vest in four equal annual installments beginning on January 29, 2027. |